8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
98%
- Product Code: 52048
CAS:
853029-57-9
| Molecular Weight: | 453.29 g./mol | Molecular Formula: | C₂₀H₁₇BrN₆O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily investigated for its potential in medicinal chemistry, particularly in the development of kinase inhibitors. Its structure suggests it may interact with specific kinase enzymes, making it a candidate for targeting signaling pathways involved in diseases like cancer. Researchers explore its efficacy in inhibiting abnormal cell proliferation, which could lead to therapeutic applications in oncology. Additionally, its unique chemical framework allows for further modification to enhance selectivity and potency, aiding in the design of novel drugs. Studies focus on its pharmacokinetic properties and binding affinity to optimize its use in targeted therapies.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Light-yellow to dark-yellow powder or crystals |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | $28.18 |
+
-
|
| 1.000 | 10-20 days | $45.09 |
+
-
|
| 5.000 | 10-20 days | $201.01 |
+
-
|
8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
This compound is primarily investigated for its potential in medicinal chemistry, particularly in the development of kinase inhibitors. Its structure suggests it may interact with specific kinase enzymes, making it a candidate for targeting signaling pathways involved in diseases like cancer. Researchers explore its efficacy in inhibiting abnormal cell proliferation, which could lead to therapeutic applications in oncology. Additionally, its unique chemical framework allows for further modification to enhance selectivity and potency, aiding in the design of novel drugs. Studies focus on its pharmacokinetic properties and binding affinity to optimize its use in targeted therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :